VNRX vs. TKNO, ABIO, ICCC, AWH, OCX, CDIO, ACHV, MURA, TARA, and MNDR
Should you be buying VolitionRx stock or one of its competitors? The main competitors of VolitionRx include Alpha Teknova (TKNO), ARCA biopharma (ABIO), ImmuCell (ICCC), Aspira Women's Health (AWH), OncoCyte (OCX), Cardio Diagnostics (CDIO), Achieve Life Sciences (ACHV), Mural Oncology (MURA), Protara Therapeutics (TARA), and Mobile-health Network Solutions (MNDR). These companies are all part of the "medical" sector.
Alpha Teknova (NASDAQ:TKNO) and VolitionRx (NYSE:VNRX) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, analyst recommendations, community ranking, institutional ownership, earnings, valuation, dividends, profitability and media sentiment.
Alpha Teknova has a net margin of -97.85% compared to Alpha Teknova's net margin of -4,379.67%. Alpha Teknova's return on equity of 0.00% beat VolitionRx's return on equity.
Alpha Teknova has a beta of 0.39, indicating that its stock price is 61% less volatile than the S&P 500. Comparatively, VolitionRx has a beta of 1.26, indicating that its stock price is 26% more volatile than the S&P 500.
Alpha Teknova currently has a consensus target price of $15.00, suggesting a potential upside of 697.87%. VolitionRx has a consensus target price of $2.50, suggesting a potential upside of 259.71%. Given VolitionRx's higher possible upside, research analysts clearly believe Alpha Teknova is more favorable than VolitionRx.
Alpha Teknova received 3 more outperform votes than VolitionRx when rated by MarketBeat users. Likewise, 33.33% of users gave Alpha Teknova an outperform vote while only 26.67% of users gave VolitionRx an outperform vote.
13.8% of Alpha Teknova shares are held by institutional investors. Comparatively, 8.1% of VolitionRx shares are held by institutional investors. 15.2% of Alpha Teknova shares are held by company insiders. Comparatively, 12.8% of VolitionRx shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
VolitionRx has lower revenue, but higher earnings than Alpha Teknova. Alpha Teknova is trading at a lower price-to-earnings ratio than VolitionRx, indicating that it is currently the more affordable of the two stocks.
In the previous week, Alpha Teknova had 1 more articles in the media than VolitionRx. MarketBeat recorded 3 mentions for Alpha Teknova and 2 mentions for VolitionRx. VolitionRx's average media sentiment score of 1.67 beat Alpha Teknova's score of 0.67 indicating that Alpha Teknova is being referred to more favorably in the media.
Summary
Alpha Teknova beats VolitionRx on 10 of the 17 factors compared between the two stocks.
Get VolitionRx News Delivered to You Automatically
Sign up to receive the latest news and ratings for VNRX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding VNRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
VolitionRx Competitors List
Related Companies and Tools
